These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 11401956
1. Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries. Taubman MA, Holmberg CJ, Smith DJ. Infect Immun; 2001 Jul; 69(7):4210-6. PubMed ID: 11401956 [Abstract] [Full Text] [Related]
2. Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. Taubman MA, Smith DJ, Holmberg CJ, Eastcott JW. Infect Immun; 2000 May; 68(5):2698-703. PubMed ID: 10768962 [Abstract] [Full Text] [Related]
8. Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase. Smith DJ, Taubman MA, Holmberg CF, Eastcott J, King WF, Ali-Salaam P. Infect Immun; 1993 Jul; 61(7):2899-905. PubMed ID: 8514393 [Abstract] [Full Text] [Related]
9. Immunogenicity and protective immunity induced by synthetic peptides associated with a catalytic subdomain of mutans group streptococcal glucosyltransferase. Smith DJ, Shoushtari B, Heschel RL, King WF, Taubman MA. Infect Immun; 1997 Nov; 65(11):4424-30. PubMed ID: 9353015 [Abstract] [Full Text] [Related]
10. Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Jespersgaard C, Hajishengallis G, Huang Y, Russell MW, Smith DJ, Michalek SM. Infect Immun; 1999 Dec; 67(12):6543-9. PubMed ID: 10569773 [Abstract] [Full Text] [Related]
12. Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase. Smith DJ, Taubman MA, King WF, Eida S, Powell JR, Eastcott J. Infect Immun; 1994 Dec; 62(12):5470-6. PubMed ID: 7960128 [Abstract] [Full Text] [Related]
15. Induction of secretory immunity with bioadhesive poly (D,L-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase. Smith DJ, Trantolo DJ, King WF, Gusek EJ, Fackler PH, Gresser JD, De Souza VL, Wise DL. Oral Microbiol Immunol; 2000 Apr; 15(2):124-30. PubMed ID: 11155176 [Abstract] [Full Text] [Related]
16. Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase. Taubman MA, Han X, Larosa KB, Socransky SS, Smith DJ. Infect Immun; 2007 Aug; 75(8):4088-96. PubMed ID: 17517867 [Abstract] [Full Text] [Related]
17. Construction of a new fusion anti-caries DNA vaccine. Niu Y, Sun J, Fan M, Xu QA, Guo J, Jia R, Li Y. J Dent Res; 2009 May; 88(5):455-60. PubMed ID: 19493890 [Abstract] [Full Text] [Related]
18. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Zhang P, Jespersgaard C, Lamberty-Mallory L, Katz J, Huang Y, Hajishengallis G, Michalek SM. Infect Immun; 2002 Dec; 70(12):6779-87. PubMed ID: 12438353 [Abstract] [Full Text] [Related]
19. Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents. Cao XX, Li YH, Ye QL, Hu X, Wang TF, Fan MW. Hum Vaccin Immunother; 2017 Oct 03; 13(10):2332-2340. PubMed ID: 28759297 [Abstract] [Full Text] [Related]